Cleared Traditional

K021023 - HEMOSIL NORMAL CONTROL (ASSAYED) (FDA 510(k) Clearance)

Also includes:
HEMOSIL NORMAL CONTROL 1 (UNASSAYED)
May 2002
Decision
46d
Days
Class 2
Risk

K021023 is an FDA 510(k) clearance for the HEMOSIL NORMAL CONTROL (ASSAYED). This device is classified as a Plasma, Coagulation Control (Class II - Special Controls, product code GGN).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on May 14, 2002, 46 days after receiving the submission on March 29, 2002.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5425.

Submission Details

510(k) Number K021023 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 2002
Decision Date May 14, 2002
Days to Decision 46 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GGN — Plasma, Coagulation Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5425